Burkholderia cepacia complex: Clinical course in cystic fibrosis patients

BMC Pulmonary Medicine

Volumn 15, Issue 1, 2015, Pages

  Folescu, Tania Wrobel ^a   da Costa, Claudia Henrique ^b   Cohen, Renata Wrobel Folescu ^a   Neto, Orlando Carlos da Conceição ^c   Albano, Rodolpho Mattos ^b   Marques, Elizabeth Andrade ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Central Hospital of Rio de Janeiro   (Brazil)

Author keywords

Body mass index; Burkholderia cepacia complex; Cystic fibrosis; Respiratory Function Tests

Indexed keywords

AMIKACIN; CEFTAZIDIME; MEROPENEM;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; BODY MASS; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA CEPACIA INFECTION; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; PANCREAS INSUFFICIENCY; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SCHOOL CHILD; SPIROMETRY; TIME SERIES ANALYSIS; TREATMENT DURATION; BURKHOLDERIA INFECTION; CASE CONTROL STUDY; HETEROZYGOTE; LONGITUDINAL STUDY; MIXED INFECTION; PATHOPHYSIOLOGY; PSEUDOMONAS INFECTION; VITAL CAPACITY;

BODY MASS INDEX; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTIONS; CARRIER STATE; CASE-CONTROL STUDIES; CHILD; COINFECTION; CYSTIC FIBROSIS; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LONGITUDINAL STUDIES; MALE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; SPIROMETRY; VITAL CAPACITY;

EID: 84952870416     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/s12890-015-0148-2     Document Type: Article

References (18)

1. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Resp Crit Care Med. 2003;168(8):918-51.
2. Correia S, Nascimento C, Pereira L, Cunha MV, Sá-Correia I, Barreto C. The clinical course of Burkholderia cepacia complex bacteria respiratory infection in cystic fibrosis patients. Rev Port Pneumol. 2008;14(1):5-26.
3. Eberl L, Tummler B. Pseudomonas aeruginosa and Burkholderia cepacia in cystic fibrosis: genome evolution, interactions and adaptation. Int J Microbiol. 2004;294:123-31.
4. Zemanick ET, Harris JK, Conway S, Konstan MW, Marshall B, Quittner AL, et al. Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy. J Cyst Fibros. 2010;9(1):1-16.
5. Gilligan PH, Kiska DL, Appleman MD. Cumitech 43, cystic fibrosis microbiology. Washington, DC: ASM Press; 2006.
6. Gilligan PH. Infections in patients with cystic fibrosis: diagnostic microbiology update. Clin Lab Med. 2014;34(2):197-217.
7. Mahenthiralingam E, Bischof J, Byrne SK, Radomski C, Davies JE, Av-Gay Y, et al. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol. 2000;38:3165-73.
8. Carvalho GM, Carvalho AP, Folescu TW, Higa L, Teixeira LM, Plotkowski MC, et al. Transient isolation of Burkholderia multivorans and Burkholderia cenocepacia from a Brazilian cystic fibrosis patient chronically colonized with Burkholderia vietnamiensis. J Cyst Fibros. 2005;4(4):267-70.
9. Rosenstein B, Cutting G. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr. 1998;132:589-95.
10. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008;153:S4-14.
11. Lee TWR, Brownlee KG, Convay SP, Denton M, Littlewood JM. Evaluation of a new definition of chronic P. aeruginosa infection in cystic fibrosis. J Cyst Fibros. 2003;2:29-34.
12. Courtney JM, Dunbar KEA, Mc Dowel A, Moore JE, Warke TJ, Stevenson M, et al. Clinical outcome of Burkholderia cepacia complex in cystic fibrosis adults. J Cyst Fibros. 2004;3:93-8.
13. Correa-Ruiz A, Girón R, Buendía B, Medina-Pascual MJ, Valenzuela C, López-Brea M, et al. Burkholderia cepacia complex infection in an adult cystic fibrosis unit in Madrid. Enferm Infecc Microbiol Clin. 2013;31(10):649-54.
14. McCloskey M, McCaughan J, Redmond AO, Elborn JS. Clinical outcome after acquisition of Burkholderia cepacia in patients with cystic fibrosis. Ir J Med Sci. 2001;170(1):28-31.
15. Konstan MW, Morgan WJ, Butler SM, Pasta DJ, Craib ML, Silva SJ, et al. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J Pediatr. 2007;151(2):134-9.
16. Frangolias DD, Mahenthiralingham E, Rae S, Raboud JM, Davidson AGF, Wittman R, et al. Burkholderia cepacia in cystic fibrosis: variable disease course. Am J Respir Crit Care Med. 1999;160:1972-7.
17. McPhail GL, Acton JD, Fenchel MC, Amin RS, Seid M. Improvements in lung function outcomes in children with cystic fibrosis are associated with better nutrition, fewer chronic pseudomonas aeruginosa infections, and dornase alfa use. J Pediatr. 2008;153(6):752-7.
18. McManus TE, Beattie D, Graham C, Moore JE, Elborn JS. Cystic fibrosis genotype and bacterial infection: a possible connection. Br J Biomed Sci. 2005;62(2):85-8.